Results

Total Results: 2,485 records

Showing results for "evaluate".

  1. Decision Modeling (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
    June 01, 2012 - Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. … It also allows one to evaluate the tradeoff in benefits, harms, and costs of different test-and treat … Evaluate previous modeling studies. … Fourth, evaluate previous modeling studies. … Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
  2. Decision Modeling (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
    June 01, 2012 - Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. … It also allows one to evaluate the tradeoff in benefits, harms, and costs of different test-and treat … Evaluate previous modeling studies. … Fourth, evaluate previous modeling studies. … Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
  3. S89 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
    October 01, 2007 - Objective: To develop and evaluate a new real-time surveillance system that uses dynamic data files and … avoidable delays between the first reports of a potential adverse event and the studies that formally evaluate … In this analysis, we evaluate 2 outcomes that meet all the above criteria: Guillain-Barre syndrome and … Example of signal detection using maximized se- quential probability ratio testing to evaluate historical … Changes in LLRs in the analysis of meningococcal conjugate vaccine using concurrent controls to evaluate
  4. effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
    January 01, 2009 - Phase 0 studies are exploratory first-in-human trials to evaluate whether the drug or agent behaves … In 1978, Freedman classified designs to evaluate and compare imaging techniques and observed a parallel … It is inevitable that such trials evaluate the effectiveness of testing as well as that of downstream … How to evaluate a diagnostic marker test. … When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
    January 01, 2009 - Phase 0 studies are exploratory first-in-human trials to evaluate whether the drug or agent behaves … In 1978, Freedman classified designs to evaluate and compare imaging techniques and observed a parallel … It is inevitable that such trials evaluate the effectiveness of testing as well as that of downstream … How to evaluate a diagnostic marker test. … When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol.pdf
    January 01, 2020 - We will primarily evaluate studies that directly compare alternative regimens but will also attempt … For KQ 3, we will also evaluate, timing with respect to delivery and subgroups with obesity or reduced … As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will evaluate each
  7. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
    April 20, 2022 - We will primarily evaluate studies that directly compare alternative regimens but will also attempt … For KQ 3, we will also evaluate, timing with respect to delivery and subgroups with obesity or reduced … As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will evaluate each
  8. effectivehealthcare.ahrq.gov/products/methods-decision-simulation-modeling/research
    February 22, 2013 - recent efforts to use modeling with a systematic review to update USPSTF cancer screening guidelines, to evaluate … the process of conducting a simultaneous systematic review and modeling exercise, and to evaluate stakeholder-perceived
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/routine-antenatal-care.pdf
    January 01, 2020 - We will evaluate outcomes as listed in the Study Eligibility Criteria Table. … As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will evaluate each … We will also evaluate the adequacy of descriptions of study participants, interventions, outcomes, and
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
    January 01, 2020 - We will evaluate outcomes as listed in the Study Eligibility Criteria Table. … As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will evaluate each … We will also evaluate the adequacy of descriptions of study participants, interventions, outcomes, and
  11. effectivehealthcare.ahrq.gov/products/schedule-visits-antenatal-care/protocol
    August 06, 2021 - We will evaluate outcomes as listed in the Study Eligibility Criteria Table. … As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will evaluate each … We will also evaluate the adequacy of descriptions of study participants, interventions, outcomes, and
  12. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/cervical-degenerative-disease
    June 11, 2021 - The purpose of this topic nomination is to evaluate all available evidence, from which, the Congress … extensively in certain areas will be asked to recuse themselves from voting and will be assigned to evaluate
  13. effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
    December 01, 2020 - • No studies evaluate instruments for predicting risk of opioid misuse, opioid use disorder or overdose … , or evaluate risk mitigation strategies to be used when prescribing opioids for episodic migraine … inability to capture such harms is due to study design as the 5 majority of trials evaluate … The trials we analyzed did not sufficiently evaluate these potential combination therapies and their
  14. S1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
    October 01, 2007 - Furthermore, premarketing studies are generally not designed to evaluate multiple endpoints, detect rare … adverse effects, evaluate health outcomes over long periods, or compare all treatment options available … The program is comprised of 3 components that work collaboratively to evaluate, synthesize, develop,
  15. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
    December 01, 2021 - KQ3: Evaluate the effect of nutritional interventions on symptoms associated w ith cancer treatment, … KQ4: Evaluate the effect of interventions intended for w eight loss prior to or during treatment in … For our contextual question, we will evaluate all studies included in KQ1-4 that include discussions … When data allow, we also will perform stratified analyses to evaluate a priori subgroups (from Table … For outcomes found to have at least moderate or high strength of evidence, we will evaluate reporting
  16. effectivehealthcare.ahrq.gov/products/restless-legs/research-protocol
    December 16, 2011 - We will evaluate methods used to define RLS, assess its severity, and measure treatment benefits and … Studies that evaluate only acute effects (< 4 weeks) of treatment. … Inclusion/Exclusion criteria for observational studies (for Key Question 2): Studies that evaluate … To evaluate harms of interest, we will include evidence from case reports or case series. … We will exclude observational studies that do not evaluate harms from treatments for RLS. B.
  17. effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-abelson-2.pdf
    January 11, 2017 - o To evaluate policy options? Slide 28 How will deliberation outputs be synthesized?
  18. effectivehealthcare.ahrq.gov/products/survival-quality/research
    April 12, 2013 - Common study limitations included significant data missing not at random, failure to evaluate patient-reported … There is a need for prospective research to evaluate: (1) any causal relationship between patient knowledge
  19. Brooks_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
    January 01, 2012 - Evaluate the peer-­‐review comments and revise the draft guidelines 9. … Continue to evaluate the guidelines and revise them  further if needed Slide 3: Prostate Cancer Advisory
  20. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_synthesizingoutputs.pdf
    May 18, 2012 - -To evaluate policy options? 2 How will deliberation outputs be synthesized?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: